# CURE > CURE - Healthcare Publication - Base URL: https://www.curetoday.com - Generated: 2026-10-20T22:43:47.902Z - Content updates: multiple times daily ## Content Access for AI Agents This site supports content negotiation for AI/LLM consumption. Request any article URL with an appropriate Accept header to receive structured content instead of HTML. **Supported content types:** - `text/markdown` — Clean Markdown with YAML frontmatter - `text/plain` — Plain text (same as Markdown) - `text/html` — Default HTML response **Example request:** ``` curl -H "Accept: text/markdown" https://www.curetoday.com/view/article-slug ``` **YAML frontmatter schema** (returned with every Markdown response): | Field | Type | Description | |-------|------|-------------| | `title` | string | Article headline | | `description` | string | Summary/excerpt (max 300 chars) | | `url` | string | Canonical article URL | | `canonical_url` | string | Canonical URL if different from `url` | | `published` | ISO 8601 | Original publication date | | `modified` | ISO 8601 | Last modification date | | `authors` | string[] | Author display names | | `content_type` | string | Content category (e.g., "News", "Clinical") | | `categories` | string[] | Taxonomy categories | | `tags` | string[] | SEO tags | | `image` | string | Featured image URL | | `publisher` | string | Publication/site name | **Discovery headers** (included on all responses): - `Link: ; rel="llms"` — RFC 8288 link to this file - `X-Llms-Txt: https://www.curetoday.com/llms.txt` — Explicit discovery header ## Usage Policy - Robots policy: [https://www.curetoday.com/robots.txt](https://www.curetoday.com/robots.txt) - Cache behavior: responses are cached for ~5 minutes (max-age=300, stale-while-revalidate=329) - Rate guidance: prefer RSS and sitemap feeds over crawling individual pages - Attribution: All content © MJH Life Sciences. Include source URLs when citing. ## Content Categories - [10 Things That Got Me Through Treatment](https://www.curetoday.com/10-things-that-got-me-through-treatment) - [All Cancers](https://www.curetoday.com/all-cancers) - [Award Programs On Demand](https://www.curetoday.com/award-programs-on-demand) - [CURE Connections ](https://www.curetoday.com/cure-connections) - [CURE Expert Connections](https://www.curetoday.com/expertconnections) - [CURE Speaking Out](https://www.curetoday.com/speaking-out) - [CURE TV](https://www.curetoday.com/cure-tv) - [CURE Talks Cancer](https://www.curetoday.com/cure-talks-cancer) - [Called to Care](https://www.curetoday.com/called-to-care) - [Cancer Horizons](https://www.curetoday.com/cancer-horizons) - [Case-Based Psych Perspectives](https://www.curetoday.com/case-based-psych-perspectives) - [Clinical Trial Corner](https://www.curetoday.com/clinical-trial-corner) - [Conference](https://www.curetoday.com/conference) - [Contributors](https://www.curetoday.com/contributors) - [Exercise of the Week](https://www.curetoday.com/exercise-of-the-week) - [Infographic](https://www.curetoday.com/infographic) - [Journal write up](https://www.curetoday.com/journal-write-up) - [Journey](https://www.curetoday.com/journey) - [News](https://www.curetoday.com/news) - [Pancreatic](https://www.curetoday.com/pancreatic) - [Podcasts](https://www.curetoday.com/podcasts) - [Press Releases](https://www.curetoday.com/press-release) - [Publications](https://www.curetoday.com/publications) - [Resource Hub](https://www.curetoday.com/resource-hub) - [Resources](https://www.curetoday.com/resources) - [Share Your Story](https://www.curetoday.com/share-your-story) - [Sponsored - No Ads](https://www.curetoday.com/sponsored) - [Stage 4](https://www.curetoday.com/stage-4-cancer) - [Summits On Demand](https://www.curetoday.com/summits-on-demand) - [Text a Survivor](https://www.curetoday.com/text-a-survivor) - [The Breast Cancer Briefing](https://www.curetoday.com/the-breast-cancer-briefing) - [Tumor](https://www.curetoday.com/tumor) - [Video Series](https://www.curetoday.com/video-series) - [Webinars](https://www.curetoday.com/webinars) - [Webinars On Demand](https://www.curetoday.com/webinars-on-demand) ## Featured Content - [Less Lymph Node Surgery May Be an Option in Locally Advanced Breast Cancer](https://www.curetoday.com/view/less-lymph-node-surgery-may-be-an-option-in-locally-advanced-breast-cancer): A study found that sentinel lymph node biopsy rarely missed remaining cancer in patients with locally advanced breast cancer whose lymph nodes respond... - [Gemcitabine Plus BCG Clears Bladder Cancer in 96% of Patients After BCG Failure](https://www.curetoday.com/view/gemcitabine-plus-bcg-clears-bladder-cancer-in-96-of-patients-after-bcg-failure): Alternating two long-used bladder treatments cleared cancer in 24 of 25 patients whose disease had returned after BCG, an early study found. A larger... - [Breast Cancer Death Gap Between Rural and Urban Women Could Widen by 2035](https://www.curetoday.com/view/breast-cancer-death-gap-between-rural-and-urban-women-could-widen-by-2035): Lower income, later diagnosis and gaps in treatment drove most of the excess deaths among rural patients, according to new research. - [ FDA Clears AI Tool Using MRI to Gauge Breast Cancer Recurrence](https://www.curetoday.com/view/fda-clears-ai-tool-using-mri-to-gauge-breast-cancer-recurrence): The FDA has cleared TumorSight Risk, software that uses a patient's existing breast MRI, pathology and clinical information to estimate the chance th... - [Diagnosed With Sarcoma at 21, She Found Her People at Mary's Place](https://www.curetoday.com/view/diagnosed-with-sarcoma-at-21-she-found-her-people-at-mary-s-place): Emma Halligan found connection at a free New Jersey retreat for women with cancer, which held its annual walk and 5K on Oct. 17. - [24 Years After Breast Cancer, I Still Hold My Breath at Mammogram Time ](https://www.curetoday.com/view/24-years-after-breast-cancer-i-still-hold-my-breath-at-mammogram-time): Twenty-four years after breast cancer, one survivor reflects on mammogram anxiety, the relief of clear results and the gratitude of living beyond canc... - [FDA Approves Jemperli for dMMR Locally Advanced Rectal Cancer](https://www.curetoday.com/view/fda-approves-jemperli-dostarlimab-for-dmmr-locally-advanced-rectal-cancer): The immunotherapy may allow some patients with a specific genetic subtype of rectal cancer to avoid surgery, radiation and chemotherapy. - [3D vs. Standard Mammograms: What a 100,000-Woman Trial Found](https://www.curetoday.com/view/3d-vs-standard-mammograms-what-a-100-000-woman-trial-found): In a randomized trial of nearly 100,000 women in Germany, 3D mammography found a larger share of breast cancers at the screening visit, but its 24% lo... - [New Mom With Stage 4 Breast Cancer Finds Hope in a Second Opinion](https://www.curetoday.com/view/new-mom-with-stage-4-breast-cancer-finds-hope-in-a-second-opinion): Eileen Carter was told she had two to three years to live after a stage 4 breast cancer diagnosis. A second opinion changed her care. - [How a Cancer Survivor Learned to Stop Hiding His Surgical Scars](https://www.curetoday.com/view/how-a-cancer-survivor-learned-to-stop-hiding-his-surgical-scars): Chester Freeman reflects on hiding the scars from his childhood tumor surgeries for decades and finally feeling comfortable in his own skin at 60. ## Feeds and Indexes - [RSS Feed](https://www.curetoday.com/rss.xml): Latest articles in XML syndication format - [Sitemap](https://www.curetoday.com/sitemap.xml): Complete URL index for all published pages - [News Sitemap](https://www.curetoday.com/sitemap-news.xml): Recent articles optimized for news indexing - [Authors Directory](https://www.curetoday.com/authors): Browse all contributors and their published work